🇺🇸 FDA
Patent

US 6225328

Adamantyl-substituted retinoids and pharmaceutical/cosmetic compositions comprised thereof

expired A61KA61K31/085A61K31/11

Quick answer

US patent 6225328 (Adamantyl-substituted retinoids and pharmaceutical/cosmetic compositions comprised thereof) held by Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma
Grant date
Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
48
CPC classes
A61K, A61K31/085, A61K31/11, A61K31/166, A61K31/192